Interv Akut Kardiol 2012; 11(5-6): 187-191

ECG monitoring after ablation for atrial fibrillation

Jan Chovančík, Veronika Bulková, Martin Fiala
Oddělení kardiologie, Nemocnice Podlesí a.s., Třinec
MDT &ndash, Medical Data Transfer, s.r.o., Brno

Cessation of anticoagulation therapy is one of the goals of catheter ablation for atrial fibrillation (AF). Asymptomatic AF recurrences may,

however, imperil an apparently cured patient by thromboembolic complication. Asymptomatic AF recurrences after catheter ablation

have been described in 2 % to more than 50 % of the patients. They may be detected by longer-term ECG monitoring; however, a comfortable

and clinically applicable recorder of continuous ECG is not currently available. This overview aims at analyzing the clinical impact

of asymptomatic AF recurrences, and options to detect it by external or implantable ECG recorders.

Keywords: atrial fibrillation, catheter ablation, ECG monitoring

Published: December 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chovančík J, Bulková V, Fiala M. ECG monitoring after ablation for atrial fibrillation. Interv Akut Kardiol. 2012;11(5-6):187-191.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kannel WB, Abbot RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982; 306: 1018-1022. Go to original source... Go to PubMed...
    2. Dries DL, Exner DV, Gersh BJ, et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998;3:695-703. Go to original source... Go to PubMed...
    3. Bulková V, Fiala M, Chovančik J, et al. Analýza nákladů na léčbu u pacientů s fibrilací síní v České republice. Cor Vasa 2008; 50: 23-27. Go to original source...
    4. Wazni OM, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs. Antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640. Go to original source... Go to PubMed...
    5. Pappone, C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atril fibrillation. The APAF study. J Am Coll Cardiol 2006; 48: 2340-2347. Go to original source... Go to PubMed...
    6. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective multi centre, randomized controlled study (Catheter Ablation For The Cure of Atrial Fibrillation Study). Eur Heart J 2006; 27: 216-221. Go to original source... Go to PubMed...
    7. Jais P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118: 2498-2505. Go to original source... Go to PubMed...
    8. Bhandari AK, Anderson JL, Gilbert EM, et al. Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. Am Heart J 1992; 124: 381-386. Go to original source... Go to PubMed...
    9. Vasamreddy CR, Dalal D, Dong J, et al. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2006; 17: 134-139. Go to original source... Go to PubMed...
    10. Page RL, Wilkinson WE, Clair WK, et al. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 1994; 89: 224-227. Go to original source... Go to PubMed...
    11. Kerr C, Boone J, Connolly S, et al. Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation, Eur Heart J 1996; 17(Suppl C): 48-51. Go to original source... Go to PubMed...
    12. Humphries KH, Kerr CR, Connolly SJ, et al. New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome, Circulation 2001; 103: 2365-2370. Go to original source... Go to PubMed...
    13. Roten L, Schilling M, Häberlin A, et al. Is 7-day event triggered ECG monitoring equivalent to 7-day Holtler ECG recording for atrial fibrillation screening? Heart 2012; doi: 10.1136/heartjnl-2011-301455. Go to original source... Go to PubMed...
    14. Roche F, Gaspoz JM, Da Costa A, et al. Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol 2002; 25: 1587-1593. Go to original source... Go to PubMed...
    15. Israel CW, Grönefeld G, Ehrlich JR, et al. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 2004; 43: 47-52. Go to original source... Go to PubMed...
    16. Defaye P, Dournaux F, Mouton E, et al. Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol 1998; 21: 250-255. Go to original source... Go to PubMed...
    17. Fetsch T, Bauer P, Engberding R, et al. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J 2004; 25: 1385-1399. Go to original source... Go to PubMed...
    18. Page RL, Tilsch TW, Connolly SJ, et al. Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide, Circulation 2003; 107: 1141-1145. Go to original source... Go to PubMed...
    19. Oral H, Chugh A, Özaydin M, et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765. Go to original source... Go to PubMed...
    20. Nademanee K, Schwab MC, Kosar EM, et al. Clinical outcomes of catheter ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol 2008; 51: 843-849. Go to original source... Go to PubMed...
    21. Themistoclakis S, Corrado A, Marchlinski FE, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010; 55: 735-743. Go to original source... Go to PubMed...
    22. Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313. Go to original source... Go to PubMed...
    23. Piorkowski C, Kottkamp H, Tanner H, et al. Value of different follow-up strategies to assess the efficacy of circumferential pulmonary vein ablation for the curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 2005; 16: 1286-1292. Go to original source... Go to PubMed...
    24. Senatore G, Stabile G, Bertaglia E, et al. Role of transtelephonic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol 2005; 45: 873-876. Go to original source... Go to PubMed...
    25. Neumann T, Ergodan A, Dill T, et al. Asymptomatic recurrences of atrial fibrillation after pulmnary vein isolation. Europace 2006; 8: 495-498. Go to original source... Go to PubMed...
    26. Edgerton JR, Mahoney C, Mack MJ, et al. Long-term monitoring after surgical ablation for atrial fibrillation: how much is enough? J Thorac Cardiovasc Surg 2011; 142: 162-165. Go to original source... Go to PubMed...
    27. Oral H, Veeradeddy S, Good E, et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol 2004; 15: 920-924. Go to original source... Go to PubMed...
    28. Verma A, Minor S, Kilicaslan F, et al. Incidence of atrial arrhythmias detected by permanent pacemakers (PPM) post-pulmonary vein antrum isolation (PVAI) for atrial fibrillation (AF): correlation with symptomatic recurrence. J Cardiovasc Electrophysiol 2007; 18: 601-606. Go to original source... Go to PubMed...
    29. Friberg L, Hammar N, Rosenquist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm cohort of atrial fibrillation. Eur Heart J 2010; 31: 967-975. Go to original source... Go to PubMed...
    30. Botto GL, Padeletti L, Santini M, et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-248. Go to original source... Go to PubMed...
    31. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures, and follow-up. Heart Rhythm 2007; 4: 816-861. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.